The PI3K pathway is one of the most altered pathways in IDH-wildtype gliomas, in consequence of PI3K kinase mutations, loss of PTEN suppressor functions, or activated mTOR (43–46) and resulted in poor prognosis (33, 34) as shown by previous researches. Here, IDH2 is linked to central nervous system cancer.